Construction and functional evaluation of a single-chain antibody fragment that neutralizes toxin Aahl from the venom of the scorpion Androctonus australis hector

被引:50
作者
Devaux, C
Moreau, E
Goyffon, M
Rochat, H
Billiald, P
机构
[1] Univ Mediterranee, Fac Med Nord, IFR Jean Roche, CNRS,UMR 6560, F-13916 Marseille 20, France
[2] Museum Natl Hist Nat, F-75231 Paris, France
[3] Fac Pharm, Tours, France
来源
EUROPEAN JOURNAL OF BIOCHEMISTRY | 2001年 / 268卷 / 03期
关键词
neurotoxins; neutralization; scFv; scorpion venom;
D O I
10.1046/j.1432-1327.2001.01923.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
9C2 is a murine monoclonal IgG that participates in the neutralization of Androctonus australis hector scorpion venom. It recognizes AahI and AahIII, two of the three main neurotoxins responsible for almost all the toxicity of the venom when injected into mammals. Using PCR we cloned the antibody variable region coding genes from 9C2 hybridoma cells and constructed a gene encoding a single chain antibody variable fragment molecule (scFv). This scFv was produced in the periplasm of Escherichia coli in a soluble and functional form and purified in a single step using protein L-agarose beads yielding 1-2 mg.L-1 of bacterial culture. scFv9C2 was predominantly monomeric but also tended to form dimeric and oligomeric structures, all capable of binding toxin AahI. The affinity of scFv and the parental mAb for toxin AahI and homologous toxin AahIII was of the same magnitude, in the nanomolar range. Similarly, purified forms of scFv9C2 completely inhibited the binding of toxin AahI to rat brain synaptosomes. Finally, scFv9C2 was efficient in protecting mice against the toxic effects of AahI after injection of the toxin and scFv to mice by the intracerebroventricular route in a molar ratio as low as 0.36 : 1. Thus, we produced a recombinant scFv that reproduces the recognition properties of the parent antibody and neutralizes the scorpion neurotoxin AahI, thereby opening new prospects for the treatment of envenomation.
引用
收藏
页码:694 / 702
页数:9
相关论文
共 42 条
[1]   Generating improved single-chain Fv molecules for tumor targeting [J].
Adams, GP ;
Schier, R .
JOURNAL OF IMMUNOLOGICAL METHODS, 1999, 231 (1-2) :249-260
[2]  
BAHRAOUI E, 1988, J IMMUNOL, V141, P214
[3]   Clinical evidence of efficient tumor targeting based on single-chain Fv antibody selected from a combinatorial library [J].
Begent, RHJ ;
Verhaar, MJ ;
Chester, KA ;
Casey, JL ;
Green, AJ ;
Napier, MP ;
HopeStone, LD ;
Cushen, N ;
Keep, PA ;
Johnson, CJ ;
Hawkins, RE ;
Hilson, AJW ;
Robson, L .
NATURE MEDICINE, 1996, 2 (09) :979-984
[4]   Engineering of a bioluminescent antigen-binding protein [J].
Billiald, P ;
Mousli, M ;
Goyffon, M ;
Vaux, D .
BIOTECHNOLOGY LETTERS, 1997, 19 (10) :1037-1041
[5]   PRODUCTION OF A FUNCTIONAL ANTI-SCORPION HEMOCYANIN SCFV IN ESCHERICHIA-COLI [J].
BILLIALD, P ;
MOTTA, G ;
VAUX, DJ .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1995, 317 (02) :429-438
[6]   MONOCLONAL DIGOXIN-SPECIFIC ANTIBODIES INDUCE DOSE-DEPENDENT AND AFFINITY-DEPENDENT PLASMA DIGOXIN REDISTRIBUTION IN RATS [J].
CANO, NJ ;
SABOURAUD, AE ;
BENMOUSSA, K ;
ROQUET, F ;
NAVARROTEULON, I ;
MANI, JC ;
SCHERRMANN, JMG .
PHARMACEUTICAL RESEARCH, 1995, 12 (05) :709-714
[7]  
Cardoso DF, 2000, SCAND J IMMUNOL, V51, P337
[8]   RECOMBINANT ANTIBODY-ALKALINE PHOSPHATASE CONJUGATES FOR DIAGNOSIS OF HUMAN IGGS - APPLICATION TO ANTI-HBSAG DETECTION [J].
CARRIER, A ;
DUCANCEL, F ;
SETTIAWAN, NB ;
CATTOLICO, L ;
MAILLERE, B ;
LEONETTI, M ;
DREVET, P ;
MENEZ, A ;
BOULAIN, JC .
JOURNAL OF IMMUNOLOGICAL METHODS, 1995, 181 (02) :177-186
[9]  
CATTERALL WA, 1977, J BIOL CHEM, V252, P8660
[10]   Venoms, antivenoms and immunotherapy [J].
Chippaux, JP ;
Goyffon, M .
TOXICON, 1998, 36 (06) :823-846